+499.5%
MRNA vs LCID
-71.9%
+571.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LCID | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.7% | -4.0% | -2.8% |
| 7D | +5.5% | -6.6% | +12.1% | +7.6% |
| 30D | +158.7% | -30.1% | +188.9% | +190.7% |
| 3M | +182.1% | -17.6% | +199.7% | +189.7% |
| 6M | +151.8% | -54.4% | +206.2% | +217.7% |
| YTD | +393.6% | -55.7% | +449.3% | +519.5% |
| 1Y | +499.5% | -71.0% | +570.5% | +753.6% |
| All | +499.5% | -71.9% | +571.4% | +753.6% |
Cumulative growth
Daily Returns
Daily percentage return beside LCID.
Daily Out/Under-Performance
Portfolio return minus LCID return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LCID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LCID wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling